McKesson Corporation (MCK) is a publicly traded Healthcare sector company. As of September 16, 2026, MCK trades at $890.78 with a market cap of $106.21B and a P/E ratio of 23.94. MCK moved -1.06% today. Year to date, MCK is +9.66%; over the trailing twelve months it is +27.98%. Its 52-week range spans $570.51 to $999.00. Analyst consensus is strong buy with an average price target of $987.75. Rallies surfaces MCK's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
13 analysts cover MCK: 0 strong buy, 10 buy, 3 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $987.75.
| Metric | Value |
|---|---|
| Price | $890.78 |
| Market Cap | $106.21B |
| P/E Ratio | 23.94 |
| EPS | $37.47 |
| Dividend Yield | 0.94% |
| 52-Week High | $999.00 |
| 52-Week Low | $570.51 |
| Volume | 250.38K |
| Avg Volume | 0 |
| Revenue (TTM) | $410.98B |
| Net Income | $5.30B |
| Gross Margin | 3.64% |
13 analysts cover MCK: 0 strong buy, 10 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $987.75.